174 related articles for article (PubMed ID: 29724170)
1. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
Ezzeldin N; El-Lebedy D; Darwish A; El Bastawisy A; Abd Elaziz SH; Hassan MM; Saad-Hussein A
BMC Cancer; 2018 May; 18(1):525. PubMed ID: 29724170
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
4. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
Fujieda M; Yamazaki H; Saito T; Kiyotani K; Gyamfi MA; Sakurai M; Dosaka-Akita H; Sawamura Y; Yokota J; Kunitoh H; Kamataki T
Carcinogenesis; 2004 Dec; 25(12):2451-8. PubMed ID: 15308589
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
[TBL] [Abstract][Full Text] [Related]
10. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
11. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.
Wassenaar CA; Ye Y; Cai Q; Aldrich MC; Knight J; Spitz MR; Wu X; Blot WJ; Tyndale RF
Carcinogenesis; 2015 Jan; 36(1):99-103. PubMed ID: 25416559
[TBL] [Abstract][Full Text] [Related]
12. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
13. Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.
Liu T; Xie CB; Ma WJ; Chen WQ
Environ Mol Mutagen; 2013 Mar; 54(2):133-40. PubMed ID: 23203414
[TBL] [Abstract][Full Text] [Related]
14. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
Patel YM; Park SL; Han Y; Wilkens LR; Bickeböller H; Rosenberger A; Caporaso N; Landi MT; Brüske I; Risch A; Wei Y; Christiani DC; Brennan P; Houlston R; McKay J; McLaughlin J; Hung R; Murphy S; Stram DO; Amos C; Le Marchand L
Cancer Res; 2016 Oct; 76(19):5768-5776. PubMed ID: 27488534
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study.
Pérez-Rubio G; López-Flores LA; Cupertino AP; Cartujano-Barrera F; Reynales-Shigematsu LM; Ramírez M; Ellerbeck EF; Rodríguez-Bolaños R; Falfan-Valencia R
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34205269
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.
Kumondai M; Hosono H; Orikasa K; Arai Y; Arai T; Sugimura H; Ozono S; Sugiyama T; Takayama T; Sasaki T; Hirasawa N; Hiratsuka M
Biol Pharm Bull; 2016; 39(1):84-9. PubMed ID: 26725431
[TBL] [Abstract][Full Text] [Related]
17. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
Hosono H; Kumondai M; Arai T; Sugimura H; Sasaki T; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):263-8. PubMed ID: 26091970
[TBL] [Abstract][Full Text] [Related]
18. CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.
Liu YL; Xu Y; Li F; Chen H; Guo SL
Tumour Biol; 2013 Oct; 34(5):2651-7. PubMed ID: 23649654
[TBL] [Abstract][Full Text] [Related]
19. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
[TBL] [Abstract][Full Text] [Related]
20. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
